One of the adverse biologic features of elderly AML as compared to younger patients is the more frequent expression of P-glycoprotein, an energy-dependent pump effluxing cytotoxic drugs out of the cell [8]. The gene discussed is ABCB1; the disease is acute myeloid leukemia.